Biotechnology - Biotechnology, Neurological

Filter

Current filters:

BiotechnologyNeurological

Popular Filters

1 to 25 of 183 results

IQWiG finds no added benefit for Biogen Idec’s Tecfidera

IQWiG finds no added benefit for Biogen Idec’s Tecfidera

08-08-2014

In its early benefit assessment, the German Institute for Quality and Efficiency in Health Care (IQWiG)…

Biogen IdecBiotechnologyGermanyMSNeurologicalPricingRegulationTecfidera

Regulus shares up on deal with Biogen for microRNA biomarkers in MS

Regulus shares up on deal with Biogen for microRNA biomarkers in MS

05-08-2014

Regulus Therapeutics has entered into a new collaboration agreement with fellow US biotech firm Biogen…

Biogen IdecBiotechnologyMultiple sclerosisNeurologicalRegulus TherapeuticsResearchUSA

Merck Serono renews alliance with San Raffaele University on neurodegeneration a decade on

Merck Serono renews alliance with San Raffaele University on neurodegeneration a decade on

24-07-2014

Merck Serono, the biotech unit of Germany’s Merck KGaA, says it is continuing its strategic alliance…

BiotechnologyHarsukh ParmarItalyMerckMerck SeronoMultiple sclerosisNeurodegenerative diseasesNeurologicalResearchResearch Hospital in Milan

Charles Ramat and Paul Freiman named co-chief executive of Neurotrope

Charles Ramat and Paul Freiman named co-chief executive of Neurotrope

21-07-2014

US-based Neurotrope, developers of diagnostic and therapeutic technologies for the treatment of neurodegenerative…

BiotechnologyBoardroomBusiness FinanceCo-chiefDiagnostic and therapeutic technologiesNeurologicalNeurotropePermanent chief executiveSyntexUSA

Biotie passes up on option to acquire Neurelis

Biotie passes up on option to acquire Neurelis

14-07-2014

Finland-based biotech firm Biotie Therapies said on Friday that it has decided not to exercise its exclusive…

Acute repetitive seizuresBiotechnologyBiotie TherapiesDiazepamFinlandHepatologyMergers & AcquisitionsNeurelisNeurologicalNRL-1Pediatric and adult epilepsyPharmaceuticalResearchtozadenant

NICE issues positive draft FAD guidance on Tecfidera

NICE issues positive draft FAD guidance on Tecfidera

11-07-2014

UK health care cost watchdog the National Institute for Health and Care Excellence (NICE) has issued…

Biogen IdecBiotechnologyMultiple sclerosisNeurologicalPricingRegulationTecfideraUK

Merck Serono to establish production of Rebif in Russia

Merck Serono to establish production of Rebif in Russia

03-07-2014

Merck Serono, the biotech unit of Germany’s Merck KGaA, plans to establish production of its multiple…

BiotechnologyMerck KGaAMerck SeronoNeurologicalPharmstandardProductionRebifRussia

Merck & Co in new accord with Bionomics for CNS research

Merck & Co in new accord with Bionomics for CNS research

24-06-2014

Australian biotech firm Bionomics has entered into a second exclusive research collaboration and license…

BionomicsBiotechnologyBNC375LicensingMerck & CoNeurologicalResearch

Isis Pharma earns $10 million milestone from Biogen

Isis Pharma earns $10 million milestone from Biogen

17-06-2014

Isis Pharmaceuticals revealed today it has earned a $10 million milestone payment from fellow US biotech…

Biogen IdecBiotechnologyFinancialIsis PharmaceuticalsNeurologicalResearch

KemPharm gets $60 million funding commitment from Deerfield

KemPharm gets $60 million funding commitment from Deerfield

06-06-2014

KemPharm, a clinical-stage US biopharmaceutical company, has entered into a $60 million financing agreement…

BiotechnologyFinancialKemPharmKP201NeurologicalResearch

AFFiRiS reports breakthrough in Alzheimer's disease with AD04

AFFiRiS reports breakthrough in Alzheimer's disease with AD04

05-06-2014

Austrian biotech firm AFFiRiS has released Phase II results with its proprietary AD04 vaccine, saying…

AD04AFFiRiSBiotechnologyGlaxoSmithKlineNeurologicalResearch

Teva ready to pay up to $825 million for Labrys Biologics, and its novel migraine treatment

Teva ready to pay up to $825 million for Labrys Biologics, and its novel migraine treatment

03-06-2014

Israel generics giant Teva Pharmaceutical Industries has entered into a definitive agreement to acquire…

AmgenBiotechnologyLabrys BiologicsLBR-101Mergers & AcquisitionsNeurologicalTeva Pharmaceutical Industries

US FDA accepts resubmission of Lemtrada sBLA by Genzyme

US FDA accepts resubmission of Lemtrada sBLA by Genzyme

30-05-2014

French drug major Sanofi (Euronext: SAN) and its subsidiary Genzyme said today that the US Food and Drug…

BiotechnologyGenzymeLemtradaNeurologicalRegulationSanofiUSA

Genzyme gains UK NICE backing for second MS drug Lemtrada

Genzyme gains UK NICE backing for second MS drug Lemtrada

28-05-2014

The UK drugs watchdog the National Institute for Health and Care Excellence (NICE) has issued final guidance…

AubagioBiotechnologyGenzymeLemtradaNeurologicalPricingRegulationSanofiUK

Eisai's R&D unit Kan Research Institute starts full-scale operation at new facility

27-05-2014

Japanese drug major Eisai Co says that its R&D subsidiary KAN Research Institute held a dedication ceremony…

BiotechnologyEisaiImmunologicalsJapanKan Research InstituteNeurologicalOncologyResearch

Positive CHMP opinion for Biogen Idec MS drug Plegridy

25-05-2014

US biotech firm Biogen Idec said on Friday that it had received a positive recommendation from the European…

Biogen IdecBiotechnologyEuropeNeurologicalPlegridyRegulation

Inovio acquires rights to pioneering DNA research in Alzheimer's disease and MS

Inovio acquires rights to pioneering DNA research in Alzheimer's disease and MS

13-05-2014

US biotech company Inovio Pharmaceuticals has acquired worldwide rights (excluding China) for early preclinical…

BiologyBiotechnologyFudan University's Shanghai Medical CollegeInovio PharmaceuticalsLicensed technologiesLicensingMedicineNeurologicalProfessorUSA

Lundbeck in deal to acquire Chelsea Therapeutics

Lundbeck in deal to acquire Chelsea Therapeutics

08-05-2014

Danish CNS specialist Lundbeck revealed today that it has entered into a definitive agreement to acquire…

BiotechnologyChelsea TherapeuticsLundbeckMergers & AcquisitionsNeurologicalNorthera

FDA issues CRL over Acorda's Plumiaz marketing application

FDA issues CRL over Acorda's Plumiaz marketing application

02-05-2014

There was disappointment for US biotech firm Acorda Therapeutics, which says it has received a complete…

Acorda TherapeuticsBiotechnologyNeurologicalPlumiazRegulationUSA

AAN 2014: Biogen Idec releases new trial data for peginterferon in MS

AAN 2014: Biogen Idec releases new trial data for peginterferon in MS

02-05-2014

US biotech firm Biogen Idec has released new two-year data from the Phase III ADVANCE clinical trial…

Biogen IdecBiotechnologyCytokinesHealth Medical PharmaHealth Medical PharmaImmune systemImmunologyNeurologicalpeginterferon beta-1aResearchUSA

Bristol-Myers acquires iPierian for $175 million upfront, plus $550 possible milestones

Bristol-Myers acquires iPierian for $175 million upfront, plus $550 possible milestones

30-04-2014

US pharma major Bristol-Myers Squibb has acquired iPierian, a privately held biotechnology company focused…

BiotechnologyBristol-Myers SquibbiPierianIPN007Mergers & AcquisitionsNeurological

AFFiRiS leads consortium for Parkinson’s vaccine funded by EU

AFFiRiS leads consortium for Parkinson’s vaccine funded by EU

29-04-2014

An international consortium of top European research teams has received significant European Union funding…

Achim SchneebergerAFFiRiSAustriaBiologyBiotechnologyEuropeExperts and basic scientistMedical University of Innsbruck's DepartmentMedicineNeurologicalResearchVaccines

Biogen Idec 1st-qtr 2014 revenue leaps 51%, driven by Tecfidera and MS franchise

23-04-2014

US biotech firm Biogen Idec first-quarter 2014 results today, including revenue of $2.1 billion, a 51%…

Biogen IdecBiotechnologyFinancialNeurologicalResearchTecfidera

Alkermes leaps on positive Ph III results for aripiprazole lauroxil for schizophrenia

Alkermes leaps on positive Ph III results for aripiprazole lauroxil for schizophrenia

09-04-2014

US biotech firm Alkermes saw its shares spike on Tuesday, after it announced positive top-line results…

AbilifyAlkermesaripiprazole lauroxilBiotechnologyLundbeckNeurologicalOtsukaRegulationResearch

1 to 25 of 183 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top